CeriBell, Inc. (CBLL) Projected Future Earnings

CeriBell Inc (CBLL) - corporate logo

Driven by unique AI-powered EEG monitoring, CeriBell, Inc. (CBLL) possesses significant pricing power within the intensive care segment. The company's projected profit on this chart reflects market expectations, where marks a new level. The model scales via cloud-based signal decoding with SaaS margins, while system implementation in clinics ensures a steady revenue stream from the sale of disposable sensors.

CeriBell EEG (CBLL): Expected Net Income from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for CeriBell Inc (CBLL)

- share price and consensus valuation forecast:
Fundamental company analysis:CBLL, CeriBell, Inc.
Finished products of CeriBell Inc

This metric assesses the fundamental value of the asset by discounting expected cash flows, allowing for a determination of the premium paid for the company's future earnings. The analysis of expected marginal profit is based on net income forecasts, which for CeriBell, Inc. (CBLL) depends directly on the scaling of SaaS subscriptions for the Rapid EEG system and the expansion of its presence in US intensive care units following FDA approvals.

Key competitors

BIIB (Biogen Inc.) - Projected Future Earnings|Future Profit neurocrine.com (NBIX)|Projected Future Earnings RGC|AXSM - Expected Net Profit|Expected Profit ACADIA Pharmaceuticals Inc ACAD|Expected Net Income XENE|Viking Therapeutics - Projected Future Earnings|Company Profit Forecast supernus.com SUPN|CPRX: Projected Future Earnings|DNLI (Denali) - Expected Profit|HRMY (Harmony Pharma) - Projected Future Earnings|Expected Net Profit Biohaven Corp BHVN|Expected Profit Amylyx Pharmaceuticals (AMLX)|Expected Profit TRVI (trevitherapeutics.com)|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex - Expected Profit|PRTA: Future Profit|Expected Net Income ALEC (Alector, Inc.)|ANNX: Projected Future Earnings|OMER - Company Profit Forecast|Expected Profit Neurogene|Net Profit Forecast ACIU (AC Immune S.A.)|Projected Future Earnings VYGR|Future Profit Neumora Corp NMRA|Scilex Holding Company - Future Profit|Company Profit Forecast tevogen.com (TVGN)|Alpha Cognition Corp - Projected Future Earnings|cogrx.com (CGTX) - Future Profit|IKT: Projected Future Earnings|SAVA (Cassava Pharma) - Expected Profit|Expected Profit Assertio Holdings|Expected Profit COYA|Expected Profit Vistagen Therapeutics (VTGN)|Expected Profit OVID (ovidrx.com)|Expected Profit Acumen Pharma ABOS|CRVO: Net Profit Forecast|Alterity Therapeutics Ltd - Projected Future Earnings|Expected Net Profit Clene Inc.|PEPG (pepgen.com) - Future Profit|jupiterneurosciences.com (JUNS) - Projected Future Earnings|Expected Profit Relmada|ANVS: Expected Net Income|Expected Profit Grace Therapeutics, Inc. (GRCE)|AIFF - Expected Net Profit|Projected Future Earnings KLTO (Klotho Neurosciences)|NRSN - Future Profit|Reviva Pharmaceuticals Holdings - Projected Future Earnings|Expected Net Profit MetaVia Inc|NeurAxis, Inc. (NRXS) - Expected Profit|Helius Medical Technologies - Expected Net Income|PASG (Passage Bio Inc.) - Projected Future Earnings|Neuphoria (NEUP) - Company Profit Forecast|Projected Future Earnings NERV|Expected Profit ATHA (Athira Pharma Corp)|Projected Future Earnings ADXN (Addex Therapeutics)|Alzamend Neuro Inc. (ALZN) - Expected Net Profit|CYCN - Expected Profit|PTIX: Expected Profit|pasitheaclinics.com (KTTA) - Expected Profit|CRGT (Cortigent) - Expected Profit|Future Profit ATXI|BCLI: Expected Net Income|Projected Future Earnings CARA|Company Profit Forecast Chromocell Therapeutics Corp|Expected Profit Eliem Therapeutics Inc. ELYM|ITCI: Net Profit Forecast|Longboard Pharmaceuticals - Projected Future Earnings|marinuspharma.com (MRNS) - Future Profit|NKGN (NKGen Biotech) - Future Profit|NRBO - Company Profit Forecast|SAGE (Sage Therapeutics, Inc) - Projected Future Earnings|Future Profit Synaptogenix, Inc (SNPX)|Projected Future Earnings TRVN|Expected Profit VIGL (vigilneuro.com)|Expected Profit Anew Medical, Inc. WENA|Cerevel Therapeutics Inc - Expected Profit